How beHuman Corp. is ready for the future of cancer screening

Wisconsin Residents Support critical access to life-saving breast imaging The Early Detection Saves Lives Coalition consists of leading patient, medical, and industry organizations who are working to enact legislation in Wisconsin that will reduce breast cancer deaths by requiring health plans to cover: Supplemental screenings for women with dense breast tissue and other high-risk factors. Diagnostic screenings for women who require follow-up exams.  Encourage your Wisconsin state lawmakers to support expanded access to supplemental and diagnostic breast imaging for Wisconsin women! Typical mammograms are less effective for women with dense breast tissue, potentially missing up to 50% of breast cancers. This happens because both dense tissue and tumors appear white on the screenings, making it difficult to detect cancer. About 50% of women have dense breast tissue, and these women are 4-6 times more likely to develop breast cancer, making early detection even more crucial. About 10% of women will be called back for additional imaging after their screening mammogram. However, studies show 1 in 5 patients would reportedly skip recommended follow-up imaging to avoid paying a deductible, which can delay critical care and impact timely breast cancer detection. While health insurers are required to cover screening mammograms who meet specific criteria without cost-sharing, there is no requirement to cover medically necessary follow-up exams. Unfortunately, the cost of supplemental or diagnostic breast imaging can range from $234 to over $1,000 in out-of-pocket costs, imposing a major financial barrier that can result in delayed cancer diagnoses and limited options. Join the Early Detection Saves Lives Coalition in advocating for the elimination of financial burdens by requiring health insurance policies to cover diagnostic or supplemental breast imaging. This would make it easier for Wisconsin women to receive additional life-saving testing and help ensure that our loved ones- mothers, daughters, and sisters, can get the care they desperately need. Expanding access to critical, life-saving screenings ensures that women who need secondary breast imaging have the same access to optimal care as those without dense breasts or other risk factors, while also removing the cost barrier. No woman should have to choose between paying a household bill and receiving potentially life-saving imaging. Too many Wisconsin women have lost their lives due to limited access to necessary healthcare—it’s time we start saving them. Access to the full spectrum of breast imaging is critical to catching breast cancer early and ensuring that women can fight back. Join us in supporting increased access to advanced screenings, because early detection saves lives! Please contact your Wisconsin legislature.

Breast Cancer Screening Available for Uninsured Cancer Services Program Holds Screening Events (October 1, 2025) — In the coming months and years, an estimated two million New Yorkers may lose their health insurance as a result of recent changes at the federal level. During this critical time, the Cancer Services Program of Fulton, Montgomery, and Schenectady Counties will continue to provide free breast cancer screening to people in our community who do not have insurance. “The Cancer Services Program has been helping people without health insurance get free mammograms for 18+ years,” said Kim Rodecker, Outreach Coordinator. “We feel very fortunate that we are able to do this life saving work.” The Cancer Services Program screens people ages 40 and older at average risk for breast cancer, and people younger than age 40 at high risk for breast cancer. If screening finds something concerning, the program will pay for any follow-up testing needed. If cancer is found, the program will help get clients who qualify enrolled in the New York State Medicaid Cancer Treatment Program where they will have full Medicaid coverage during their cancer treatment. “Finding breast cancer early gives the best chance for successful treatment. We urge you to talk to your health care provider about scheduling a mammogram. If you do not have health insurance or a health care provider, please contact the Cancer Services Program to see how we can help,” said Kim Rodecker, Outreach Coordinator. The Cancer Services Program has the following screening events scheduled to reach people in need of a mammogram: October 7th at Nathan Littauer Hospital October 15th and 18th at St. Mary's Breast Center @ Rao Pavilion October 28th at Bellevue Women's Center The Cancer Services Program also provides free cancer screening for cervical and colorectal cancer to those eligible. Call 518-841-3726 for more information about our screening services or to register for any of our screening events.

A new study claims #Medicaid expansion has led to an improvement in long-term survival rates especially for those in rural or high-poverty areas. #healthcare https://lnkd.in/g-j-9z5D

A new ASCO Post article highlights new analyses from CancerCare’s insurance red tape study, presented this week at the American Society of Clinical Oncology (ASCO) Quality Care Symposium. Half of patients who required prior authorization for cancer treatment reported direct involvement by themselves and their families in the process, often facing substantial time burdens. “This study highlights how cancer patients and their families are being pulled into the insurance prior authorization process, at the expense of their time, health, and well-being," said Alexandra Zaleta, PhD, Vice President, Research & Insights at CancerCare. "While doctors and care teams often take the lead, half of patients told us they also had to roll up their sleeves by personally making calls, filing paperwork, or chasing down approvals. Many lost days, and some lost a full week or more, just to a single instance of trying to get approval for the care their doctors had already prescribed. By documenting the scale of this hidden burden, our research shows that prior authorization is not just an administrative step⁠—it’s a serious barrier to quality care.” You can read the ASCO Post article here: https://lnkd.in/eR6wEJqp Learn more about other findings from CancerCare's Red Tape Report:🔗 https://lnkd.in/eVf5E245 #PriorAuthorization #PatientAdvocacy #HealthEquity #ASCOQLTY25

A Story of Protection & Hope Two years ago, Maya decided to purchase a medical plan plus early‐care critical illness coverage. She set aside about 3%–5% of her income for it—something she thought she might never need, but believed in the peace of mind it would bring. One afternoon, she noticed a small lump in her left breast. It didn’t hurt. She felt scared, but recalled how having insurance could help. She made an appointment with a doctor. The doctor recommended several tests: • Blood tests • Cancer markers • Mammogram • Fine needle biopsy After waiting anxiously, the biopsy results confirmed early‐stage breast cancer. Because she had been diligent and caught it early, treatment options were good. The hospitalisation costs—surgery, hospital stay, diagnostics—were all covered by her medical card. At the same time, she received a payout from her early‐care critical illness policy, which helped pay for other medical costs, plus everyday living expenses: rent, groceries, bills. In short, she could focus on healing—chemotherapy, appointments, rest—without the constant worry about finances. Maya feels gratitude every day: she made the right decision to spend a small portion of her income to protect herself. That small sacrifice two years ago meant she was ready when she needed help the most. Relevant Statistics: Breast Cancer in Malaysia To understand why stories like Maya’s matter, here are some of the latest breast cancer statistics in Malaysia: • Breast cancer is the most common cancer among Malaysian women. • The age‐standardised incidence rate (ASR) is about 34.1 per 100,000 women based on 2012-2016 data. • One in about 19 women in Malaysia will develop breast cancer in their lifetime. • As many as 50%+ of Malaysian women are diagnosed at late stages (stage 3 or 4) of breast cancer. • For early stage diagnosis (Stage 1), only a small percentage (around 17.5%) are diagnosed at that stage. Stage 2 makes up about 34-35%. • Survival rates are much higher when breast cancer is detected early. 💖 Are you well protected? Many people only realize the importance of coverage when the unexpected happens. Take a moment to review your medical and early critical illness protection — it could make all the difference. If you’re unsure whether your current plan is enough, I’m here to help. Let’s review it together and make sure you’re fully covered. 💪✨ #happyhelpingpeople #ZenithGroup #MedicalCoverage #CriticalIllnessProtection

Where you live shouldn’t determine your healthcare outcomes, but our analysis shows that state alone explains nearly half of the variation in breast cancer reimbursement. When Medicare benchmarks are added, those gaps widen even further. In our latest blog, Trek breaks down how state, commercial payer strategy, and Medicare policy intersect to decide who gets paid the most for the same service, and what that means for providers working toward more equitable reimbursement. 🔗 https://lnkd.in/d5-8Wj-Q

Whistleblower Lawsuit Alleges Kidneys Were Withheld from Poorer Patients at Dallas Hospital A whistleblower lawsuit filed in Dallas accuses two of North Texas’s largest hospitals of steering donated kidneys away from poorer patients in favor of more affluent ones. The suit, brought by former transplant director Patrek Chase, alleges that organs initially rejected at Parkland Health — a public hospital serving low-income residents — were later approved and transplanted at UT Southwestern Medical Center, which serves a wealthier clientele. According to court filings, Chase documented 36 cases in a single year in which kidneys turned down for Parkland patients were subsequently transplanted at UT Southwestern. The same physicians, the lawsuit claims, made both sets of decisions — first declaring the organs unsuitable for Parkland patients, then approving them for use across town. The allegations, first reported by Michael Marks for Texas Standard, suggest a pattern that could reveal systemic inequities in the nation’s organ allocation process. Parkland, a safety-net hospital funded by taxpayers, primarily serves uninsured and Medicaid patients. UT Southwestern, a state academic medical center, treats a broader mix of private insurance and Medicare recipients. Chase’s lawsuit also targets regional organ procurement organizations (OPOs), which are responsible for recovering and distributing donor organs. The complaint raises concerns that financial incentives — particularly Medicare’s reimbursement system, which pays hospitals for each transplant performed — may be distorting medical judgment and fairness. If substantiated, the claims could expose a troubling divide between rich and poor in the U.S. transplant system, one that undermines public confidence in what is supposed to be a life-saving, need-based process. Experts note that kidney transplants are governed by federal rules designed to ensure equitable access, but whistleblowers have long warned of inconsistencies between hospitals. Neither Parkland Health nor UT Southwestern has publicly commented on the specifics of the case. The Texas Standard reports that both institutions are reviewing the allegations internally. The lawsuit is expected to test not only hospital ethics but also federal oversight of organ distribution — a system already under scrutiny for transparency and accountability. For patients waiting on dialysis, the stakes could not be higher.

UnitedHealth is expanding its cancer care coverage with a focus on early detection and patient navigation. The new benefit design aims to improve outcomes and lower costs by emphasizing screening, coordinated care, and access to advanced treatments. For benefits managers, this expansion highlights how major carriers are adapting to rising cancer prevalence while responding to employer demand for more comprehensive coverage. See how these changes could influence your plan strategy and vendor conversations.

What Two Weeks of Waiting Means in Oncology In oncology, two weeks can mean the difference between a treatable and terminal cancer diagnosis. Yet for many clinics, that’s the reality of waiting for prior authorization. Across the U.S., nearly 93% of physicians report that patients “sometimes, often, or always” face care delays from prior authorization (AMA, 2024). Even a few days can close the window for early intervention or limit access to less aggressive treatment options. The American Medical Association illustrates this: "A patient’s imaging request sat pending for 13 days while the clinic exchanged documentation with a payer portal. By the time approval arrived, the patient’s condition had progressed, changing the course of treatment entirely." These aren’t isolated stories. According to the AMA, 23% of physicians have seen prior authorization lead to hospitalization, and 18% report life-threatening events as a result of delays. How have prior auth's impacted your patients? At Hidalga Technologies, we’re building simple to use tools that shorten those wait times to help clinics move from paperwork to care faster. Prior authorization done right, the first time, with hidalga. AMA link: https://loom.ly/lg5EfXA